On the other hand, a PSA cut-off of 18.95 ng/mL would correctly identify 97.5% of all bone metastasis, while a PSA cut-off of 20.85 ng/mL would correctly identify 95% of all bone metastasis. Here, KLK3 is linked to bone metastasis.